Simple chitin-based cell culture platform for production of biopharmaceuticals.
3D cell culture
Biopharmaceuticals
Chitin
Continuous manufacturing
Scale-up culture
Journal
Biotechnology letters
ISSN: 1573-6776
Titre abrégé: Biotechnol Lett
Pays: Netherlands
ID NLM: 8008051
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
19
01
2023
accepted:
19
07
2023
medline:
28
8
2023
pubmed:
22
8
2023
entrez:
22
8
2023
Statut:
ppublish
Résumé
Gene therapy using viral vectors and antibody-based therapies continue to expand within the pharmaceutical market. We evaluated whether Cellhesion The results of Cell Counting Kit-8 assay and LDH assay revealed that Cellhesion Cellhesion
Identifiants
pubmed: 37606752
doi: 10.1007/s10529-023-03422-7
pii: 10.1007/s10529-023-03422-7
doi:
Substances chimiques
Biological Products
0
Chitin
1398-61-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1265-1277Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature B.V.
Références
Draper SJ, Heeney JL (2010) Viruses as vaccine vectors for infectious diseases and cancer. Nat Rev Microbiol 8(1):62–73. https://doi.org/10.1038/nrmicro2240
doi: 10.1038/nrmicro2240
pubmed: 19966816
Faravelli S, Campioni M, Palamini M, Canciani A, Chiapparino A, Forneris F (2021) Optimized recombinant production of secreted proteins using human embryonic kidney (HEK293) cells grown in suspension. Bio Protoc 11(8):e3998. https://doi.org/10.21769/BioProtoc.3998
doi: 10.21769/BioProtoc.3998
pubmed: 34124299
pmcid: 8160536
Fliedl L, Grillari J, Voglauer RG (2015) Human cell lines for the production of recombinant proteins: on the horizon. N Biotechnol 32(6):673–679. https://doi.org/10.1016/j.nbt.2014.11.005
doi: 10.1016/j.nbt.2014.11.005
pubmed: 25529337
Genzel Y (2015) Designing cell lines for viral vaccine production: where do we stand? Biotechnol J 10(5):728–740. https://doi.org/10.1002/biot.201400388
doi: 10.1002/biot.201400388
pubmed: 25903999
Genzel Y, Olmer RM, Schäfer B, Reichl U (2006) Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Vaccine 24(35–36):6074–6087. https://doi.org/10.1016/j.vaccine
doi: 10.1016/j.vaccine
pubmed: 16781022
Jayakumar R, Chennazhi KP, Srinivasan S, Nair SV, Furuike T, Tamura H (2011) Chitin scaffolds in tissue engineering. Int J Mol Sci 12(3):1876–1887. https://doi.org/10.3390/ijms12031876
doi: 10.3390/ijms12031876
pubmed: 21673928
pmcid: 3111639
Jelsch M, Roggo Y, Kleinebudde P, Krumme M (2021) Model predictive control in pharmaceutical continuous manufacturing: a review from a user’s perspective. Eur J Pharm Biopharm 159:137–142. https://doi.org/10.1016/j.ejpb.2021.01.003
doi: 10.1016/j.ejpb.2021.01.003
pubmed: 33429008
Kida K, Kanaki T, Gao S, Hatanaka D, Iwakami M, Liu S, Horikawa M, Ono M, Chang D (2022) A novel 3D culture system using a chitin-based polysaccharide material produces high-quality allogeneic human UCMSCs with dispersed sphere morphology. Cells 11(6):995. https://doi.org/10.3390/cells11060995
doi: 10.3390/cells11060995
pubmed: 35326446
pmcid: 8947357
Kim BG, Park HW (2016) Tetrahydrofolate increases suspension growth of dihydrofolate reductase-deficient Chinese hamster ovary DG44 cells in chemically defined media. Biotechnol Prog 32(6):1539–1546. https://doi.org/10.1002/btpr.2351
doi: 10.1002/btpr.2351
pubmed: 27578320
Kim ES, Kida K, Mok J, Seong Y, Jo SY, Kanaki T, Horikawa M, Kim KH, Kim TM, Park TS, Park J (2021) Cellhesion VP enhances the immunomodulating potential of human mesenchymal stem cell-derived extracellular vesicles. Biomaterials 271:120742. https://doi.org/10.1016/j.biomaterials.2021.120742
doi: 10.1016/j.biomaterials.2021.120742
pubmed: 33706111
Lee S (2017) Present and future for continuous manufacturing: FDA perspective. In: 3rd FDA/PQRI conference on advancing product quality. https://pqri.org/wp-content/uploads/2017/02/1-Lee-PQRI-for-CM-2017.pdf
Lennaertz A, Knowles S, Drugmand JC, Castillo J (2013) Viral vector production in the integrity
Li C, Samulski RJ (2020) Engineering adeno-associated virus vectors for gene therapy. Nat Rev Genet 21(4):255–272. https://doi.org/10.1038/s41576-019-0205-4
doi: 10.1038/s41576-019-0205-4
pubmed: 32042148
Li F, Vijayasankaran N, Shen A, Kiss R, Amanullah A (2010) Cell culture processes for monoclonal antibody production. Mabs 2(5):466–479. https://doi.org/10.4161/mabs.2.5.12720
doi: 10.4161/mabs.2.5.12720
pubmed: 20622510
pmcid: 2958569
Liang K, Luo H, Li Q (2023) Enhancing and stabilizing monoclonal antibody production by Chinese hamster ovary (CHO) cells with optimized perfusion culture strategies. Front Bioeng Biotechnol 11:1112349. https://doi.org/10.3389/fbioe.2023.1112349
doi: 10.3389/fbioe.2023.1112349
pubmed: 36741761
pmcid: 9895834
Marks DM (2003) Equipment design considerations for large scale cell culture. Cytotechnology 42(1):21–33. https://doi.org/10.1023/A:1026103405618
doi: 10.1023/A:1026103405618
pubmed: 19002925
pmcid: 3449506
Nam JH, Ermonval M, Sharfstein ST (2009) The effects of microcarrier culture on recombinant CHO cells under biphasic hypothermic culture conditions. Cytotechnology 59(2):81–91. https://doi.org/10.1007/s10616-009-9196-x
doi: 10.1007/s10616-009-9196-x
pubmed: 19412658
pmcid: 2698439
Nelson AL, Dhimolea E, Reichert JM (2010) Development trends for human monoclonal antibody therapeutics. Nat Rev Drug Discov 9(10):767–774. https://doi.org/10.1038/nrd3229
doi: 10.1038/nrd3229
pubmed: 20811384
Pollock J, Coffman J, Ho SV, Farid SS (2017) Integrated continuous bioprocessing: economic, operational, and environmental feasibility for clinical and commercial antibody manufacture. Biotechnol Prog 33(4):854–866. https://doi.org/10.1002/btpr.2492
doi: 10.1002/btpr.2492
pubmed: 28480535
pmcid: 5575510
Rghei AD, Stevens BAY, Thomas SP, Yates JGE, McLeod BM, Karimi K, Susta L, Bridle BW, Wootton SK (2021) Production of adeno-associated virus vectors in cell stacks for preclinical studies in large animal models. J vis Exp. https://doi.org/10.3791/62727
doi: 10.3791/62727
pubmed: 34279499
Rodrigues ME, Costa AR, Fernandes P, Henriques M, Cunnah P, Melton DW, Azeredo J, Oliveira R (2013) Evaluation of macroporous and microporous carriers for CHO-K1 cell growth and monoclonal antibody production. J Microbiol Biotechnol 23(9):1308–1321. https://doi.org/10.4014/jmb.1304.04011
doi: 10.4014/jmb.1304.04011
pubmed: 23711520
Shamshina JL, Gurau G, Block LE, Hansen LK, Dingee C, Walters A, Rogers RD (2014) Chitin-calcium alginate composite fibers for wound care dressings spun from ionic liquid solution. J Mater Chem B 2(25):3924–3936. https://doi.org/10.1039/c4tb00329b
doi: 10.1039/c4tb00329b
pubmed: 32261644
Shao HJ, Lee YT, Chen CS, Wang JH, Young TH (2010) Modulation of gene expression and collagen production of anterior cruciate ligament cells through cell shape changes on polycaprolactone/chitosan blends. Biomaterials 31(17):4695–4705. https://doi.org/10.1016/j.biomaterials.2010.02.037
doi: 10.1016/j.biomaterials.2010.02.037
pubmed: 20304482
Sousa MFQ, Silva MM, Giroux D, Hashimura Y, Wesselschmidt R, Lee R, Roldão A, Carrondo MJT, Alves PM, Serra M (2015) Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, vertical-wheel bioreactor system: impact of bioreactor design on performance of microcarrier-based cell culture processes. Biotechnol Prog 31(6):1600–1612. https://doi.org/10.1002/btpr.2158
doi: 10.1002/btpr.2158
pubmed: 26289142
Urquhart L (2020) Top companies and drugs by sales in 2019. Nature reviews drug discovery. https://www.nature.com/articles/d41573-020-00047-7
Yang J, Guertin P, Jia G, Lv Z, Yang H, Ju D (2019) Large-scale microcarrier culture of HEK293T cells and Vero cells in single-use bioreactors. AMB Express 9(1):70. https://doi.org/10.1186/s13568-019-0794-5
doi: 10.1186/s13568-019-0794-5
pubmed: 31127400
pmcid: 6534633
Yu P, Huang Y, Zhang Y, Tang Q, Liang G (2012) Production and evaluation of a chromatographically purified Vero cell rabies vaccine (PVRV) in China using microcarrier technology. Hum Vaccin Immunother 8(9):1230–1235. https://doi.org/10.4161/hv.20985
doi: 10.4161/hv.20985
pubmed: 22894963
pmcid: 3579903